Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by BlueJays9293on Feb 28, 2024 8:58pm
144 Views
Post# 35905357

RE:RE:RE:RE:RE:i count 8

RE:RE:RE:RE:RE:i count 8At 90 patients Tigris was 60% enrolled, at 105 patients Tigris will be 70% enrolled, at 120 patients Tigris will be 80% enrolled, at 135 patients Tigris will be 90% enrolled, at 150 patients Tigris will be fully enrolled.

Each of these levels represents a degree of confidence, a probability number, that tell you the odds of this ARR holding true all the way until the end results.

So say for example, Tigris is running a 20% ARR at 60% enrolled, there is a very specific degree of confidence number that the ARR will carry true until full enrollment.

At 105 patients (70% enrolled) running at 20% ARR, this degree of confidence/probability shoots up,

at 120 patients (80% enrolled) running at 20% ARR, this degree of confidence/probablity shoots up,

at 135 patients (90% enrolled) running at 20% ARR, this degree of confidence/probabilty shoot's up.

at 149 patients (99.333% enrolled) running at 20% ARR, this degree of confidence/probabilty basically goes to 100% because that last and final patient will have very little effect on the running ARR of the prior 149.

The biggest question in my mind, is at what confidence/probability level does Baxter feel comfortable firing off a billion plus dollars in their stock/currency???  Baxter refused to see the raw data, which was a very prescient move on their part in my opinion, but I guarantee they have a little bit more color than just 'exceeding expectations'.


<< Previous
Bullboard Posts
Next >>